User profiles for María Montoro

Maria R. Belando Montoro

Profesora Titular de Universidad (UCM)
Verified email at edu.ucm.es
Cited by 925

[BOOK][B] Mundo escrito y mundo no escrito

I Calvino, M Barenghi, AS Gijón, MJC Montoro - 2006 - siruela.com
El Buen Lector espera las vacaciones con impaciencia. Para las semanas que pasará en
una solitaria localidad marítima o montañosa, ha reservado cierto número de lecturas de las …

Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis

E Naredo, L Valor, I De la Torre, M Montoro… - …, 2015 - academic.oup.com
Objective. To investigate the predictive value of synovitis detected by Doppler US in relation
to failed tapering of biologic therapy (BT) in RA patients in sustained clinical remission. …

Ultrasound joint inflammation in rheumatoid arthritis in clinical remission: how many and which joints should be assessed?

…, D Hernández, M Montoro… - Arthritis care & …, 2013 - Wiley Online Library
Objective To investigate the sensitivity for detecting subclinical synovitis of different reduced
joint ultrasound (US) assessment models as compared with a comprehensive US …

[BOOK][B] Relaciones literarias entre Jorge Luis Borges y Umberto Eco

MJC Montoro, R Capozzi - 1999 - books.google.com
… Rosario Montoro Murillo, y Pablo María Acebrón Tolosa, entusiasta italianista castellano-manchego,
ayudados por las estudiantes Ana María González, Mercedes Barreda y María de …

[HTML][HTML] Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study

…, JD Cañete, C Montilla, M Abad, M Montoro… - Arthritis research & …, 2017 - Springer
Background Patients with psoriatic arthritis (PsA) experience functional impairment and
reduced quality of life, and thus patient global assessment in PsA is explained mainly by the …

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0

…, C Campos-Fernández, M Montoro… - Annals of the …, 2012 - ard.bmj.com
Objective To investigate in rheumatoid arthritis (RA) the rate and reason of discontinuation
of tumour necrosis factor (TNF) antagonists over the past decade. Methods RA patients in …

Localización en parques científicos y tecnológicos y cooperación en I+ D+ i como factores determinantes de la innovación

Montoro-Sánchez, EM Mora-Valentín… - Revista Europea de …, 2012 - Elsevier
El objetivo de este trabajo es analizar los efectos directos de la localización de las empresas
en parques científicos y tecnológicos y de la cooperación en I+D+i en la innovación de las …

Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study

…, V Martin, A Cabez, S Gomez, M Montoro - …, 2018 - academic.oup.com
Objectives The aims were to evaluate the prevalence of anti-drug antibodies (ADA) in patients
with RA or SpA experiencing secondary failure to anti-TNF therapy and to correlate ADA …

[PDF][PDF] Análisis de las competencias adquiridas en los estudios de Dirección de Empresas y su grado de aplicación en las prácticas en empresas

Montoro Sánchez, EM Mora Valentín… - Revista Complutense …, 2012 - core.ac.uk
Dada la importancia concedida a las competencias en el marco del EEES, en el presente
trabajo se pretende conseguir un doble objetivo. En primer lugar, tras identificar las …

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the …

…, M Barceló, S Farietta, M Montoro… - British Journal of …, 2017 - academic.oup.com
Background Information on the safety of tumour necrosis factor (TNF) antagonists frequently
arises from their use in rheumatic diseases, their first approved indications, and is later …